Candel Therapeutics (CADL) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.74
-0.45
-0.16
0.13

Details

Expected EPS
-0.37462
Actual EPS
0.13
Surprise EPS
0.5
Surprise Percent
+134.7%

Description

Candel Therapeutics (CADL) has reported earnings of 0.13 per share for Q2 2025.

0 Comments

Share your thoughts